New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareAlpha-GPC vs SS-31 (Elamipretide)

Alpha-GPC vs SS-31 (Elamipretide)

Side-by-side comparison of key properties, dosing, and research.

Cognitive Enhancement
Alpha-GPC
Anti-Aging & Longevity
SS-31 (Elamipretide)
Summary
Alpha-GPC is the most bioavailable form of choline, readily crossing the blood-brain barrier to rapidly increase acetylcholine levels. It enhances cognitive performance, supports GH secretion, and is used as an essential complement to many nootropic peptides (especially those that increase acetylcholine demand like Noopept and Dihexa).
SS-31 (Elamipretide) is a synthetic mitochondria-targeting tetrapeptide that concentrates in the inner mitochondrial membrane and protects cardiolipin from oxidative damage. It is one of the most promising mitochondrial longevity compounds, studied in clinical trials for heart failure, renal disease, and age-associated mitochondrial dysfunction.
Half-Life
~4–6 hours
~2–5 hours
Admin Route
Oral, SubQ
SubQ
Research
Typical Dose
300–600 mg
5–10 mg
Frequency
1–2x daily
Daily to several times per week
Key Benefits
  • Rapidly raises brain acetylcholine levels
  • Enhances memory formation and recall
  • Prevents headaches from nootropic peptides (choline donor)
  • Stimulates growth hormone secretion (modest)
  • Improves attention and processing speed
  • Neuroprotective in Alzheimer's and cognitive decline
  • Approved in Europe for Alzheimer's therapy
  • Enhances power output in athletes (pre-workout)
  • Restores mitochondrial function and ATP production
  • Protects inner mitochondrial membrane cardiolipin
  • Reduces mitochondrial reactive oxygen species (ROS)
  • Improves exercise capacity and reduces fatigue
  • Cardioprotective — studied in heart failure trials
  • Renoprotective — reduces ischemic kidney injury
  • Anti-aging via mitochondrial preservation
  • Potential in neurodegenerative disease prevention
Side Effects
  • Headache (paradoxically, from excess acetylcholine at very high doses)
  • Nausea at doses > 1200 mg
  • Dizziness
  • Fatigue at high doses
  • +1 more
  • Injection site irritation
  • Nausea (rare)
  • Generally well-tolerated in clinical trials
Stacks With